Clinical Trial

Post Market Clinical Follow-Up KeriFuse®

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The general objective of this study is to evaluate the performances and the safety related to the KeriFuse® intramedullary arthrodesis implant and associated instrumentation used in accordance with their approved labelling and instruction for use. Performance and safety of KeriFuse® intramedullary arthrodesis implant will be established on short and middle-terms in regards to the implant life-cycle.
Protocol Amendment History 1 change
notable Primary completion moved earlier: 2025-12 -> 2025-04-11 2026-08-13
Trial Details
NCT Number NCT06546332
Lead Sponsor Keri Medical SA
Conditions Arthritis
Enrollment 97 participants
Start Date 2022-07-05
Primary Completion 2025-04-11 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-12